OMCS
CLDX icon

Old Mutual Customised Solutions’s Celldex Therapeutics CLDX Stock Holding History

Old Mutual Customised Solutions’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-133
Closed -$31K – 861
2013
Q2 		$31K Buy
+133
New +$26.2K 0.01% 915

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Old Mutual Customised Solutions's CLDX Position: Q3 2013 in Review

Old Mutual Customised Solutions sold out of Celldex Therapeutics (CLDX) in Q3 2013, closing a stake of 133 shares — an estimated $31K sold.

Old Mutual Customised Solutions first reported a position in CLDX in Q2 2013 and held it in 1 quarter. The position peaked at $31K in Q2 2013. 150 funds tracked by Wall St. Rank hold CLDX as of Q3 2013.

  • Old Mutual Customised Solutions reported no remaining Celldex Therapeutics position as of Q3 2013 after selling out during the quarter.
  • Old Mutual Customised Solutions sold 133 Celldex Therapeutics shares in Q3 2013, an estimated $31K.
  • Old Mutual Customised Solutions first reported a position in Celldex Therapeutics in Q2 2013 and held it in 1 quarter.
  • Old Mutual Customised Solutions's Celldex Therapeutics position peaked at $31K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2013.

Based on Old Mutual Customised Solutions's 13F filing for Q3 2013, filed 6 Nov 2013.